Lataa...
Yes and Lyn play a role in nuclear translocation of the Epidermal Growth Factor Receptor
The epidermal growth factor receptor (EGFR) is a central regulator of tumor progression in human cancers. Cetuximab is an anti-EGFR antibody that has been approved for use in oncology. Previously we investigated mechanisms of resistance to cetuximab using a model derived from the non-small cell lung...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3381861/ https://ncbi.nlm.nih.gov/pubmed/22430206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2012.90 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|